We have identified a protein kinase in im-
undetermined.
It is known that kinases often copurify with their physiologically active substrates as a result of being structurally linked to them. The best known examples include the cAMPdependent protein kinase that copurifies with microtubules (12) and the cAMP-independent kinase that copurifies with neurofilament proteins (13) . With this in mind, we have examined purified PHF preparations for enzyme activities that might be significant in their formation. Such studies have previously been impossible because of the harsh detergent and protease treatments used in isolation of PHFs. To obtain PHFs in a form amenable to functional characterization, we have resorted to affinity chromatography with the monoclonal antibody (mAb) Alz-50 used as the affinity ligand.
From among the spectrum of antibodies that have been used in studies of Alzheimer brain pathology, Alz-50 has emerged as a particularly useful probe. The diagnostic potential of the antibody (14) (15) (16) stems from its ability to detect a T epitope that is abundant in the brains of individuals with AD but is not detected in similar regions of normal adult brain (17) . Alz-50 immunoreactivity is also observed in the brains of patients with Down syndrome, Pick disease, and progressive supranuclear palsy (14, 20, 21) .
The purification of PHFs in the present study exploits the ability ofAlz-50 to discriminate between native forms ofnormal T and PHF T. Although PHFs obtained by this method have a protein composition similar to that of PHFs isolated by other procedures (7, 22, 23) was continued for 1 hr. The coupling efficiency was generally >90%. The immunoadsorbent was poured into a column and washed with TBS. The column was maintained at 40C and all chromatography steps were conducted at this temperature. Before application of sample, the column was treated with at least 2 bed vol of eluting buffer (3 M potassium thiocyanate) followed by 5 bed vol of TBS. The 27,000 x g supernatant was loaded onto the immunoaffinity column at a flow rate of -25 ml/hr. Nonspecific binding was reduced by washing the immunoadsorbent with at least 30 bed vol of TBS. Subsequently, adsorbed protein was eluted with eluting buffer. Fractions were assayed for protein concentration with the Quantigold protein reagent (Bio-Rad). Peak fractions were dialyzed against TBS and aliquots were stored at -700C until used. As determined by ELISA, 100%o of the Alz-50 immunoreactivity of the 27,000 x g supernatant was recovered in the eluate. The typical protein yield was 60-80 ,ug per ml of eluate, representing an -10,000-fold enrichment of the antigen relative to the homogenate.
Samples of AD-associated proteins (ADAPs) were provided by H. Ghanbari and B. Miller (Abbott Laboratories). In this preparation, a 100,000 x g pellet from AD brain was further enriched for Alz-50 reactivity by washing with CHAPS and by extraction with 3.5 M guanidine hydrochloride. The resulting ADAP preparation contains the three major Alz-50-positive bands and is similar to the immunoaffinity PHF preparation with respect to all other cross-reactive mAbs (25 The incubation was conducted at room temperature for 10 min. Samples were resolved by electrophoresis on SDS/12% polyacrylamide gel and were further processed according to standard procedures.
Quantitation of Incorporated 32p into PHFs. Gels were dried and subjected to autoradiography. PHF proteins (57-68 kDa only) were cut out from the gels using the autoradiogram as a trace. The gel bands were digested with 200 ,ul of 30% hydrogen peroxide for 4 hr at 50'C, and radioactivity was estimated by liquid scintillation counting.
Immunoprecipitation with mAbs 38 and 126. The respective purified mAbs (IgGls) were coupled to goat anti-mouse IgG-coated inert microspheres (Kirkegaard and Perry Laboratories, Gaithersburg, MD) and were used to precipitate PHF protein as described (26 phosphate into these proteins (Fig. 2C) . Phosphorylation was also prevented when 1 mM EDTA was introduced into the standard incubation mixture. This EDTA-induced inhibition is overcome by 2 mM Mg2+ but not by 2 mM Ca2'. Moreover, the presence of 0.2 mM Ca2+ together with 2 mM Mg2+ does not produce any increase in incorporation of phosphate into PHFs (Fig. 2C) .
Experiments aimed at determining the nature of the phosphorylating activity showed that regulators of the Ca2+/ calmodulin kinases (calmodulin at 50 pug/ml and trifluperazine at 100 l M), protein kinase C (phorbol 12-myristate 13-acetate at 100 ,uM and phosphatidylserine at 100 AuM), cAMP-dependent protein kinase (cAMP at 20 ttg/ml, and the Walsh inhibitor at 4 units), and cGMP-dependent protein kinase (20 ,uM cGMP) are all ineffective in altering the phosphorylation activity ofthe PHF preparation (not shown). It was subsequently attempted to classify the kinase based on its preference for exogenous substrates. Casein rather than mixed histone is found to be the better acceptor protein for the kinase (Fig. 3A) , while protamine and various individual fractions of histone are not phosphorylated by the PHF preparation (data not shown). To distinguish between casein kinase I-and casein kinase II-like activities, the sensitivity to heparin and to the polyamines spermine and protamine was assessed. None of these agents modifies the rate of phosphorylation of casein by the PHF preparation. Endogenous phosphorylation of the PHF proteins is also unaffected by heparin, spermine, or protamine (Fig. 3B) .
PHF-Associated Kinase Activity Is Sensitive to Hemin (Ferriprotoporphyrin EX Chloride). One compound found to exert an inhibitory effect on the kinase of the PHF preparation is the blood porphyrin hemin. At 10 ,uM, hemin totally abolishes phosphorylation of the PHF proteins (Fig. 3B) as well as phosphorylation of casein by the PHF preparation (Fig.   3A ). In addition, incubation of PHF with 10 1LM hemin results in inhibition of Alz-50 immunoreactivity with PHF on electrophoretic blots (Fig. 3B) .
The ADAP preparation was also observed to contain a protein kinase activity that exhibits properties similar to the kinase of the immunoaffinity PHF preparation. Thus, the ADAP-associated kinase preferentially phosphorylates casein, and this phosphorylation is effectively reduced by 10 ,uM hemin. Incubation with 10 uM hemin also inhibits endogenous phosphorylation of the ADAP proteins, as well as subsequent Alz-50 immunoreactivity with the proteins on electrophoretic blots (Fig. 3C) .
Analysis of specific phosphorylation sites in the PHF proteins reveals that serine is the predominant acceptor of labeled phosphate, although some incorporation of label into threonine residues is also observed (Fig. 4A) .
Kinetic Properties of the Kinase. Kinetic experiments were conducted to obtain estimates of the affinity of the kinase for ATPand the stoichiometry ofphosphorylation. In the first case, aliquots of the PHF preparation were incubated with concentrations of ATP ranging from 50 ,uM to 2 mM, and the incorporation of label into the major triplet proteins was quantitated as described. The Km for ATP was estimated from a Lineweaver-Burk plot of the data to be 6 MM (Fig. 4B) . The dependence of the degree ofphosphorylation on the duration of exposure to [-32P]ATP was examined at 200 MM unlabeled ATP. A plot of the extent of phosphorylation vs. time of incubation is shown in Fig. 4C . Phosphorylation approaches a maximum at 40 min and then it plateaus. Based on an average molecular mass of64 kDa, the stoichiometry ofphosphorylation was determined to be 0.64 mol per mol of PHF.
Kinase Is Tightly Associated with PHF. As a first step toward evaluating the relationship between the kinase and PHFs, the occurrence ofthe kinase was examined in immunoaffinity preparations from cases of Pick disease and Down syndrome, where Alz-50 immunoreactivity is detected, and in normal brain tissue, which lacks Alz-50 reactivity. As expected, no Alz-50-positive bands are observed in the preparation from normal brain and no endogenous phosphorylation is detected (Fig. SA) . Moreover, the normal brain preparation does not phosphorylate casein (data not shQwn). Immunoaffinity preparations from Pick disease, Down syndrome, and AD, respectively, contain increasing amounts of Alz-50 antigen. Endogenous phosphorylation of these preparations is observed and demonstrates an increase in parallel with the increase in abundance of PHF protein (Fig. SA) .
To further examine the association of the kinase with the PHF proteins, the immunoaffinity preparation was subjected to immunoprecipitation using two additional mAbs (mAb 38 and 126) reacting at independent epitopes on PHFs. The immunoprecipitates and the supernatants were then incubated with [32P]ATP and the phosphorylated products were analyzed by a standard procedure. With both mAbs, the kinase activity as measured by phosphorylation ofthe PHF proteins was found to coprecipitate with the immunoreactive PHF proteins (Fig. SB) . In contrast, the nonspecific IgG1 did not precipitate PHFs or the phosphorylating activity (Fig. 5B) . (Fig.  SC) . In contrast, phosphorylation of the PHF proteins was sustained at all dilutions (Fig. 5C) . (28) . Because of its preference for utilizing casein as an acceptor protein and the lack of inhibition by heparin or activation by spermine and protamine, the enzyme has a resemblance to casein kinase 1 (29) . Like the 37-kDa casein kinase I, the kinase of the PHF preparation has a dependence on Mg2', a Km for ATP of 6 ,uM, and a specificity for ATP as phosphoryl donor (data not shown). However, it differs from the above kinase in its apparent ability to modify threonine residues in addition to serine. An intriguing aspect of the PHF kinase is its sensitivity to hemin. Accompanying this inhibition of phosphorylation is the loss of immunoreactivity of the proteins with Alz-50. This loss of Alz-50 immunoreactivity is not due to proteolysis, since silver staining of the gels did not reveal any alterations in banding pattern and the PHF proteins are still recognized by other mAbs (data not shown). One biochemical action of hemin that is believed to be of physiological relevance is its inhibition of the 95-kDa heme-regulated inhibitor (HRI), an effector of reticulocyte protein synthesis (18) . Phosphorylation of eukaryotic initiation factor 2a (the only known substrate for the HRI) is completely inhibited by [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] ,uM hemin (19) . It is unlikely that the kinase of the PHF preparation is related to HRI since it does not phosphorylate initiation factor 2a (unpublished data). However, hemin eliminates the phosphorylation of PHFs at concentrations similar to those of HRI, raising the possibility that hemin is involved in regulation of phosphorylation of PHFs in AD. However, further studies are required to establish this relationship and elucidate its significance.
Additional experiments in the present paper provide cogent evidence for a functional relationship between the hemin-sensitive protein kinase and PHFs: the activity varies in direct proportion to the abundance of PHFs in various neurological diseases and is not found in preparations from normal brain that are deficient in PHFs; Alz-50 antigens prepared according to an entirely independent protocol (i.e., ADAP) also have a similar hemin-sensitive kinase activity; the kinase remains associated with PHFs even after a second round of immunoselection with mAbs 38 and 126; phosphorylation of PHFs is unaffected by dilution, whereas the phosphorylation of added casein is affected by dilution; the activity is also observed when PHFs are isolated by affinity chromatography through a column of PHF-1 (unpublished data). Furthermore, the properties of protein kinase preclude the likelihood of contamination from classified kinases, especially those that phosphorylate r (i.e., protein kinase C, Ca2+/calmodulin kinase, and casein kinase II). In view of the resistance of phosphorylation of the ADAP preparation to treatment with CHAPS and 3.5 M guanidine hydrochloride, two detergents capable of eliminating protein-protein interactions, it is suggested that the kinase is a component of PHFs. This contention is strengthened by the observed coincidence of the kinase with PHFs after ion-exchange chromatography on Mono Q or Mono S columns and phosphocellulose chromatography (data not shown).
In light of the multiplicity of phosphorylation sites in PHFs, a general imbalance in phosphorylation/dephosphorylation homeostasis in neurodegenerative disease might be alleged. Thus, PHF may be the ultimate result of sequential addition of phosphates into normal r. An alternative possibility is that only one phosphorylation site is sufficient to generate PHFs, while the remainder are introduced post hoc. In this regard, an unusual protein kinase associated with PHFs may be a reasonable culprit for posttranslational modification of these proteins. We have subsequently observed that prior dephosphorylation greatly enhances phosphorylation of PHFs by the endogenous kinase (unpublished data), indicating that this site is phosphorylated in PHFs in vivo. However, it has yet to be determined whether the action of the hemin-sensitive PHF kinase is imperative for precipitation of the tangled mass of protein that destines neurons for death.
